Item 5. Other Information

(c) Director and Officer Trading Arrangements

The following table describes, for the quarterly period covered by this report, each trading arrangement for the sale or purchase of Company securities adopted, terminated or for which the amount, pricing or timing provisions were modified by our directors and officers that is either (1) a contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (a “Rule 10b5-1 trading arrangement”) or (2) a “non-Rule 10b5-1 trading arrangement” (as defined in Item 408(c) of Regulation S-K):


Name (Title)			Action Taken (Date of Action)			Type of Trading Arrangement			Nature of Trading Arrangement			Duration of Trading Arrangement			Aggregate Number of Securities to be Purchased or Sold
Kimberly Salem-Jackson (Chief Marketing Officer)			Adoption (August 25, 2023)			Rule 10b5-1 trading arrangement			Sales			Until May 24, 2024, or such earlier date upon which all transactions are completed or expire without execution			6,736 shares of common stock

Table of Contents

Previous: Item 1A. Risk Factors · Next: Item 6. Exhibits